Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.
作者信息
Das Tuyelee, Nandy Samapika, Ghosh Arabinda, Chandran Deepak, Sharma Anil K, Dhama Kuldeep, Dey Abhijit
机构信息
Department of Life Sciences, Presidency University, Kolkata, West Bengal.
Department of Botany, Microbiology Division, Gauhati University, Gauhati, Assam.
出版信息
Int J Surg. 2023 May 1;109(5):1528-1530. doi: 10.1097/JS9.0000000000000077.
Abstract
摘要
相似文献
1
Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.获批用于天花的药物特考韦瑞马（Tpoxx）对猴痘的疗效：最新进展与未来展望
Int J Surg. 2023 May 1;109(5):1528-1530. doi: 10.1097/JS9.0000000000000077.
2
New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.新型抗菌药物：特考韦瑞用于治疗人类猴痘病毒。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0122622. doi: 10.1128/aac.01226-22. Epub 2022 Nov 14.
3
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.在非人类灵长类动物中联合使用特考韦瑞玛特和 ACAM2000TM：特考韦瑞玛特治疗对 ACAM2000 免疫原性和针对致死性猴痘病毒攻击的疗效的影响。
Vaccine. 2020 Jan 16;38(3):644-654. doi: 10.1016/j.vaccine.2019.10.049. Epub 2019 Oct 31.
4
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.天花潜在治疗药物溴昔洛韦的药代动力学和疗效在致命猴痘病毒动物模型中的研究。
mSphere. 2021 Feb 3;6(1):e00927-20. doi: 10.1128/mSphere.00927-20.
5
The development and approval of tecoviromat (TPOXX), the first antiviral against smallpox.天花病毒的第一种抗病毒药物特考韦瑞（TPOXX）的研发与获批。
Antiviral Res. 2019 Aug;168:168-174. doi: 10.1016/j.antiviral.2019.06.005. Epub 2019 Jun 7.
6
Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.替考韦瑞玛，一种用于治疗天花感染的p37包膜蛋白抑制剂。
IDrugs. 2010 Mar;13(3):181-91.
7
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.特考韦瑞玛治疗天花概述及拓展的抗正痘病毒应用。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):331-344. doi: 10.1080/14787210.2020.1819791. Epub 2020 Sep 15.
8
Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.使用天花抗病毒药物tecovirimat（ST-246）单独治疗或与ACAM2000疫苗联合治疗，作为猴痘病毒感染的症状出现后疗法是有效的。
Antimicrob Agents Chemother. 2015 Jul;59(7):4296-300. doi: 10.1128/AAC.00208-15. Epub 2015 Apr 20.
9
Tecovirimat: First Global Approval.特考韦瑞玛特：全球首次批准。
Drugs. 2018 Sep;78(13):1377-1382. doi: 10.1007/s40265-018-0967-6.
10
Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection.一种天花药物能治疗猴痘吗？同情用药使用tecovirimat治疗猴痘感染。
Eur J Intern Med. 2023 Jan;107:105-106. doi: 10.1016/j.ejim.2022.09.017. Epub 2022 Sep 22.
引用本文的文献
1
Development of a Broad-Spectrum Pan-Mpox Vaccine via Immunoinformatic Approaches.通过免疫信息学方法开发广谱泛痘疫苗。
Int J Mol Sci. 2025 Jul 25;26(15):7210. doi: 10.3390/ijms26157210.
2
A bioinformatic analysis to systematically unveil shared pathways and molecular mechanisms underlying monkeypox and its predominant neurological manifestations.一项生物信息学分析，旨在系统揭示猴痘及其主要神经学表现背后的共同途径和分子机制。
Front Cell Infect Microbiol. 2025 Jul 2;15:1506687. doi: 10.3389/fcimb.2025.1506687. eCollection 2025.
3
Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.猴痘（原名猴痘）：发病机制、预防和治疗。
Signal Transduct Target Ther. 2023 Dec 27;8(1):458. doi: 10.1038/s41392-023-01675-2.
4
Immunoinformatics and reverse vaccinology approach in designing a novel highly immunogenic multivalent peptide-based vaccine against the human monkeypox virus.免疫信息学和反向疫苗学方法在设计一种针对人类猴痘病毒的新型高免疫原性多价肽基疫苗中的应用。
Front Mol Biosci. 2023 Nov 22;10:1295817. doi: 10.3389/fmolb.2023.1295817. eCollection 2023.
Zotero 插件